E Fund Management Co., Ltd.

SEC CIK: 0001842296
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

CTMX holding history

CytomX Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTMX overview All 13F holders of CTMX Full Q2 2026 holdings

Shares (Q2 2026): 31,214
Value: $117.1K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of CTMX by E Fund Management Co., Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	31,214	$117.1K	<0.1%	+1,067+3.5%	Added	Holders
Q1 2026	30,147	$141.7K	<0.1%	–	No prior filing	Holders